Company Filing History:
Years Active: 2020
Title: Innovations by HongXiu Ning in Shock Wave Treatment
Introduction
HongXiu Ning is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medical treatments, particularly through his innovative work on low energy shock wave therapy. His research focuses on optimizing dosages for treating vital organs, which has the potential to enhance patient outcomes in various medical applications.
Latest Patents
HongXiu Ning holds a patent titled "Optimal dosages for low energy shock wave treatment of vital organs." This patent addresses the lack of guidance in prior art regarding effective minimum and safe maximum dosages for low energy acoustic shockwaves applied to sensitive organs. Through extensive experimentation with cultured cells, live animals, and disease models, he has established safe and efficacious dosage ranges for vital organs such as the brain, pancreas, kidneys, liver, and spleen, as well as for skin, peripheral nerves, and skeletal muscles.
Career Highlights
Throughout his career, HongXiu Ning has worked with prestigious institutions, including the University of California and Allogene Therapeutics, Inc. His work has been instrumental in advancing the understanding of shock wave therapy and its applications in medicine.
Collaborations
Some of his notable coworkers include Tom F Lue and Ching-Shwun Lin. Their collaborative efforts have contributed to the development of innovative treatment methodologies in the field.
Conclusion
HongXiu Ning's contributions to the field of low energy shock wave treatment represent a significant advancement in medical technology. His research not only provides valuable insights into effective treatment dosages but also paves the way for future innovations in patient care.